HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis.

AbstractBACKGROUND:
The relationship between resistin and non-alcoholic steatohepatitis (NASH) is not clear, some studies claimed that serum resistin levels were associated with neither the presence of NASH nor its severity, others declared that serum resistin was related with inflammation and fibrosis in NASH. Our animal study verified that the distribution of resistin in the liver is correlated with inflammation in NASH. However, there is no pertinent study in humans.
METHODS:
Thirty patients with NASH, 28 simple steatosis, and 43 controls were recruited. Blood was collected for resistin, liver chemistries, fasting insulin and some metabolic parameters. Liver histology was scored according to NAFLD activity scoring system. Hepatic resistin expression was examined by real-time polymerase chain reaction, immunohistochemistry. Resistin protein expression was confirmed by western blotting in 13 patients with concomitant NAFLD and gallstone.
RESULTS:
Serum resistin was significantly elevated in both NASH and simple steatotic subjects compared with controls (all P < 0.05). Hepatic resistin was significantly increased in NASH patients in both mRNA and protein levels than those in simple steatosis and control subjects (all P < 0.05). Both serum and hepatic resistin had a correlation with obesity, but not with insulin resistance. The distribution of resistin positive cells was predominantly in perisinusoidal cells (such as Kupffer cells and hepatic stellate cells) in human NASH. Multivariate analysis revealed that waist-hip ratio, higher serum triglyceride, and hyperresistinemia were independent factors related to higher grade of steatosis; whereas hepatic resistin and serum cytokeratin predict NASH and severity of liver fibrosis.
CONCLUSIONS:
Hepatic resistin overexpression in NASH patients is associated with the severity of liver inflammation and fibrosis. Liver-derived resistin may be involved in the pathogenesis of human NASH.
AuthorsChuan Shen, Cai-Yan Zhao, Wei Wang, Ya-Dong Wang, Hui Sun, Wei Cao, Wei-Yan Yu, Li Zhang, Ru Ji, Meng Li, Jian Gao
JournalBMC gastroenterology (BMC Gastroenterol) Vol. 14 Pg. 39 (Feb 23 2014) ISSN: 1471-230X [Electronic] England
PMID24559185 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Resistin
  • Triglycerides
  • Keratins
Topics
  • Adult
  • Case-Control Studies
  • Fatty Liver (blood, metabolism, pathology)
  • Female
  • Hepatic Stellate Cells (chemistry)
  • Humans
  • Insulin Resistance
  • Keratins (blood)
  • Kupffer Cells (chemistry)
  • Liver Cirrhosis (metabolism, pathology)
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease
  • Obesity (metabolism)
  • Prospective Studies
  • RNA, Messenger (analysis)
  • Resistin (analysis, blood, genetics)
  • Triglycerides (blood)
  • Up-Regulation
  • Waist-Hip Ratio

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: